Effect of Recombinant Human Interferon α-2b Spray on Herpangina

NCT03266601 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

668

Enrollment

OTHER

Sponsor class

Conditions

Herpangina

Interventions

DRUG: Recombinant Human Interferon α-2b Spray
DRUG: Ribavirin

Sponsor

Children's Hospital of Fudan University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]